2591 logo

Guangzhou Innogen Pharmaceutical Group Co., Ltd Stock Price

SEHK:2591 Community·HK$20.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2591 Share Price Performance

HK$43.78
-13.47 (-23.53%)
HK$43.78
-13.47 (-23.53%)
Price HK$43.78

2591 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with very low risk.

2 Risks
0 Rewards

Guangzhou Innogen Pharmaceutical Group Co., Ltd Key Details

CN¥56.4m

Revenue

CN¥6.0m

Cost of Revenue

CN¥50.5m

Gross Profit

CN¥272.4m

Other Expenses

-CN¥221.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.49
89.45%
-393.09%
5.9%
View Full Analysis

About 2591

Founded
2014
Employees
105
CEO
Qinghua Wang
WebsiteView website
www.innogenpharm.com

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in development of drugs. Its products are used for treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.

Recent 2591 News & Updates

Recent updates

No updates